Yantai Zhenghai Bio-Tech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 56.48%

Yantai Zhenghai Bio-Tech Co Ltd (300653) has an Asset Resilience Ratio of 56.48% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Yantai Zhenghai Bio-Tech Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥544.95 Million

≈ $79.74 Million USD Cash + Short-term Investments

Total Assets

CN¥964.85 Million

≈ $141.19 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Yantai Zhenghai Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Yantai Zhenghai Bio-Tech Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Yantai Zhenghai Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Yantai Zhenghai Bio-Tech Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥544.95 Million	56.48%
Total Liquid Assets	CN¥544.95 Million	56.48%

Asset Resilience Insights

Very High Liquidity: Yantai Zhenghai Bio-Tech Co Ltd maintains exceptional liquid asset reserves at 56.48% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Yantai Zhenghai Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yantai Zhenghai Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Yantai Zhenghai Bio-Tech Co Ltd (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Yantai Zhenghai Bio-Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	51.57%	CN¥505.43 Million ≈ $73.96 Million	CN¥980.11 Million ≈ $143.42 Million	-5.24pp
2023-12-31	56.80%	CN¥598.61 Million ≈ $87.60 Million	CN¥1.05 Billion ≈ $154.21 Million	+2.67pp
2022-12-31	54.13%	CN¥534.21 Million ≈ $78.17 Million	CN¥986.90 Million ≈ $144.42 Million	+6.20pp
2021-12-31	47.92%	CN¥445.18 Million ≈ $65.14 Million	CN¥928.92 Million ≈ $135.93 Million	+16.70pp
2020-12-31	31.23%	CN¥251.55 Million ≈ $36.81 Million	CN¥805.54 Million ≈ $117.88 Million	-20.89pp
2019-12-31	52.12%	CN¥375.48 Million ≈ $54.94 Million	CN¥720.45 Million ≈ $105.42 Million	--

pp = percentage points

About Yantai Zhenghai Bio-Tech Co Ltd

SHE:300653 China Biotechnology

Market Cap

$393.78 Million

CN¥2.69 Billion CNY

Market Cap Rank

#13626 Global

#4082 in China

Share Price

CN¥14.95

Change (1 day)

+6.10%

52-Week Range

CN¥14.09 - CN¥23.13

All Time High

CN¥53.33